Ankai Xu

808 total citations
14 papers, 545 citations indexed

About

Ankai Xu is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ankai Xu has authored 14 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ankai Xu's work include Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers) and Spinal Cord Injury Research (2 papers). Ankai Xu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers) and Spinal Cord Injury Research (2 papers). Ankai Xu collaborates with scholars based in China. Ankai Xu's co-authors include Jinti Lin, Jiakang Jin, Chao Qian, Jianan Lou, Wei Yu, Huimin Tao, Yitian Wang, Kaishun Xia, Xiumao Li and Fangcai Li and has published in prestigious journals such as ACS Nano, Acta Biomaterialia and Frontiers in Oncology.

In The Last Decade

Ankai Xu

14 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ankai Xu China	11	219	172	107	104	101	14	545
Peidong Liu China	15	275 1.3×	179 1.0×	54 0.5×	166 1.6×	135 1.3×	37	685
Thusanth Thuraisingam Canada	14	202 0.9×	209 1.2×	125 1.2×	45 0.4×	92 0.9×	25	698
Shun Xu China	14	504 2.3×	76 0.4×	173 1.6×	224 2.2×	44 0.4×	22	712
Ki Jung Sung South Korea	13	443 2.0×	177 1.0×	94 0.9×	241 2.3×	291 2.9×	33	814
Shenming Wang China	12	249 1.1×	171 1.0×	22 0.2×	127 1.2×	87 0.9×	25	601
Gentao Fan China	11	200 0.9×	52 0.3×	49 0.5×	135 1.3×	50 0.5×	24	393
Yuanlin Xu China	12	324 1.5×	105 0.6×	80 0.7×	162 1.6×	82 0.8×	33	715
Liangsheng Fan China	17	325 1.5×	133 0.8×	34 0.3×	163 1.6×	232 2.3×	29	591

Countries citing papers authored by Ankai Xu

Since Specialization

Citations

This map shows the geographic impact of Ankai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankai Xu more than expected).

Fields of papers citing papers by Ankai Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankai Xu. The network helps show where Ankai Xu may publish in the future.

Co-authorship network of co-authors of Ankai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ankai Xu. A scholar is included among the top collaborators of Ankai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankai Xu. Ankai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Yu, Wei, Ankai Xu, Bing Liu, et al.. (2024). mTORC1 accelerates osteosarcoma progression via m6A-dependent stabilization of USP7 mRNA. Cell Death Discovery. 10(1). 127–127. 11 indexed citations

Yu, Wei, Jinti Lin, Tao Yu, et al.. (2023). The regulation of N6‐methyladenosine modification in PD‐L1‐induced anti‐tumor immunity. Immunology and Cell Biology. 101(3). 204–215. 2 indexed citations

Qu, Liyan, Jiakang Jin, Jianan Lou, et al.. (2022). The nuclear transportation of PD-L1 and the function in tumor immunity and progression. Cancer Immunology Immunotherapy. 71(10). 2313–2323. 11 indexed citations

Jin, Jiakang, Pengcheng Yuan, Wei Yu, et al.. (2022). Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy. ACS Nano. 16(7). 10327–10340. 118 indexed citations

Lin, Jinti, Ankai Xu, Jiakang Jin, et al.. (2022). MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. OncoImmunology. 11(1). 2024941–2024941. 65 indexed citations

Wang, Tiecheng, Jiakang Jin, Chao Qian, et al.. (2021). Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. Cancer Cell International. 21(1). 295–295. 28 indexed citations

Zhang, Man, Yang Bai, Chang Xu, et al.. (2021). Novel optimized drug delivery systems for enhancing spinal cord injury repair in rats. Drug Delivery. 28(1). 2548–2561. 19 indexed citations

Jin, Jiakang, Jinti Lin, Ankai Xu, et al.. (2021). CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment. Frontiers in Oncology. 11. 111 indexed citations

Xu, Ankai, Chao Qian, Jinti Lin, et al.. (2021). Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma. Genes. 12(11). 1685–1685. 9 indexed citations

10.

Zhu, Jian, Kaishun Xia, Wei Yu, et al.. (2019). Sustained release of GDF5 from a designed coacervate attenuates disc degeneration in a rat model. Acta Biomaterialia. 86. 300–311. 47 indexed citations

11.

Xu, Ankai, et al.. (2019). Comprehensive therapeutics targeting the corticospinal tractfollowing spinal cord injury. Journal of Zhejiang University SCIENCE B. 20(3). 205–218. 4 indexed citations

12.

Zhu, Jian, Wei Yu, Yitian Wang, et al.. (2019). lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration. Stem Cell Research & Therapy. 10(1). 344–344. 60 indexed citations

13.

Gong, Zhe, Kaishun Xia, Ankai Xu, et al.. (2019). Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury. Current Stem Cell Research & Therapy. 15(4). 321–331. 35 indexed citations

14.

Xia, Kaishun, Zhe Gong, Jian Zhu, et al.. (2018). Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration. Current Stem Cell Research & Therapy. 14(1). 57–64. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peidong Liu Breakdown of academic impact, for papers by Thusanth Thuraisingam Breakdown of academic impact, for papers by Shun Xu Breakdown of academic impact, for papers by Ki Jung Sung Breakdown of academic impact, for papers by Shenming Wang Breakdown of academic impact, for papers by Gentao Fan Breakdown of academic impact, for papers by Yuanlin Xu Breakdown of academic impact, for papers by Liangsheng Fan